Despite these limitations, our study substantially enhances our understanding of immunologic responses to SARS-CoV-2 mRNA vaccination in individuals with SLE, while also providing insights that may improve our understanding of mRNA vaccine responses in AID generally. This evidence concerns the gene AICDA and systemic lupus erythematosus.